- Title
- In silico identification of selective novel hits against the active site of wild type mycobacterium tuberculosis pyrazinamidase and its mutants
- Creator
- Gowo, Prudence
- ThesisAdvisor
- Bishop, Ozlem Tastan
- Subject
- Mycobacterium tuberculosis
- Subject
- Pyrazinamide
- Subject
- Multidrug resistance
- Subject
- Antitubercular agents
- Subject
- Molecular dynamics
- Subject
- Hydrogen bonding
- Subject
- Ligand binding (Biochemistry)
- Subject
- Dynamic Residue Network
- Date
- 2021-04
- Type
- thesis
- Type
- text
- Type
- Masters
- Type
- MSc
- Identifier
- http://hdl.handle.net/10962/178007
- Identifier
- vital:42898
- Description
- The World Health Organization declared Tuberculosis a global health emergency and has set a goal to eradicate it by 2035. However, effective treatment and control of the disease is being hindered by the emerging Multi-Drug Resistant and Extensively Drug Resistant strains on the most effective first line prodrug, Pyrazinamide (PZA). Studies have shown that the main cause of PZA resistance is due to mutations in the pncA gene that codes for the target protein Pyrazinamidase (PZase). Therefore, this study aimed to identify novel drug compounds that bind to the active site of wild type PZase and study the dynamics of these potential anti-TB drugs in the mutant systems of PZase. This approach will aid in identifying drugs that may be repurposed for TB therapy and/or designed to counteract PZA resistance. This was achieved by screening 2089 DrugBank compounds against the whole wild type (WT) PZase protein in molecular docking using AutoDOCK4.2. Compound screening based on docking binding energy, hydrogen bonds, molecular weight and active site proximity identified 47 compounds meeting all the set selection criteria. The stability of these compounds were analysed in Molecular Dynamic (MD) simulations and were further studied in PZase mutant systems of A3P, A134V, A146V, D8G, D49A, D49G, D63G, H51P, H137R, L85R, L116R, Q10P, R140S, T61P, V139M and Y103S. Generally, mutant-ligand systems displayed little deviation from the WT systems. The compound systems remained compact, with less fluctuations and more hydrogen bond interactions throughout the simulation (DB00255, DB00655, DB00672, DB00782, DB00977, DB01196, DB04573, DB06414, DB08981, DB11181, DB11760, DB13867, DB13952). From this research study, potential drugs that may be repurposed for TB therapy were identified. Majority of these drugs are currently used in the treatment of hypertension, menopause disorders and inflammation. To further understand the mutant-ligand dynamic systems, calculations such as Dynamic Residue Network (DRN) may be done. Also, the bioactivity of these drugs on Mycobacterium tuberculosis may be studied in wet laboratory, to understand their clinical impart in vivo experiments.
- Description
- Thesis (MSc) -- Faculty of Science, Biochemistry and Microbiology, 2021
- Format
- computer, online resource, application/pdf, 1 online resource (132 pages), pdf
- Publisher
- Rhodes University, Faculty of Science, Biochemistry and Microbiology
- Language
- English
- Rights
- Gowo, Prudence
- Rights
- All Rights Reserved
- Hits: 8606
- Visitors: 8824
- Downloads: 431
Collections
RU Department of Biochemistry and Microbiology (2015-)
| Thumbnail | File | Description | Size | Format | |||
|---|---|---|---|---|---|---|---|
| View Details | SOURCE1 | GOWO-MSC-TR21-99.pdf | 3 MB | Adobe Acrobat PDF | View Details |